| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/25/2007 | CN101002809A Medicine preparation containing extractive of Zi-Jin-Sha, preparing method and use thereof |
| 07/25/2007 | CN101002800A Medicine composition containing extract of cinnabar, and application thereof |
| 07/25/2007 | CN101002796A Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith |
| 07/25/2007 | CN101002780A New pharmaceutical compositions containing flibanserin polymorph a |
| 07/25/2007 | CN101002770A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 07/25/2007 | CN101002760A Application of chlorogenic acid for preparing medicine to treat diabetes complications |
| 07/25/2007 | CN101002756A Percutaneous adhering preparation of hydrochloride nefopam |
| 07/25/2007 | CN101002589A Health-care medicine tea for sobering and taking care of liver and kidney |
| 07/24/2007 | US7247766 Double transgenic mice overexressing human beta secretase and human APP-London |
| 07/24/2007 | US7247728 Bicyclic N-arylamides |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247652 β-benzyloxyaspartate derivatives with amino group on benzene ring |
| 07/24/2007 | US7247651 2,7-substituted indoles |
| 07/24/2007 | US7247645 Dihydropyridine derivatives |
| 07/24/2007 | US7247644 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
| 07/24/2007 | US7247643 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/24/2007 | US7247641 Compounds, derivatives, compositions, preparation and uses |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247638 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives. |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |
| 07/24/2007 | US7247630 Nitrogen compounds such as 3-(5-hydroxyhexyl)-1-methyl-1H-imidazo(2,1-f)purine-2,4(3H,6H)-dione, used for prophylaxis of diseases associated with cytokine intracellular signal transduction |
| 07/24/2007 | US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/24/2007 | CA2411277C Neurotoxin implant |
| 07/24/2007 | CA2230350C Combination preparation for use in dementia |
| 07/24/2007 | CA2192480C Benzopyrans and their use as therapeutic agents |
| 07/19/2007 | WO2007082208A2 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 07/19/2007 | WO2007081909A2 Forms of dolasetron mesylate and processes for their preparation |
| 07/19/2007 | WO2007081907A2 Crystalline forms of dolasetron base and processes for preparation thereof |
| 07/19/2007 | WO2007081341A1 Controlled release formulation of divalproic acid and its derivatives |
| 07/19/2007 | WO2007081060A1 Therapeutic agent for neuropathic pain |
| 07/19/2007 | WO2007080898A1 Sustained-release hydrogel preparation |
| 07/19/2007 | WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same |
| 07/19/2007 | WO2007080721A1 Therapeutic agent for lewy body disease and prophylactic agent for lewy body disease |
| 07/19/2007 | WO2007080263A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 07/19/2007 | WO2007080201A1 Use of low doses of igf-i in ageing, owing to the neuroprotective, antioxidant and anabolic effects thereof |
| 07/19/2007 | WO2007080010A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | WO2007079977A2 Nutraceutical compositions comprising tripeptides |
| 07/19/2007 | WO2007079961A1 Substituted thiazoles and their use for producing drugs |
| 07/19/2007 | WO2007079957A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/19/2007 | WO2007079927A1 Substituted imidazoline derivatives |
| 07/19/2007 | WO2007079842A1 Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 07/19/2007 | WO2007079840A2 Benzochromene derivatives |
| 07/19/2007 | WO2007079695A1 An extract of xanthoceras sorbifolia bunge and extraction and uses thereof |
| 07/19/2007 | WO2007079691A1 The composition of tcm for treating depression, formulations containing the same, process for preparation and use thereof |
| 07/19/2007 | WO2007079681A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 07/19/2007 | WO2007079593A1 Novel melatonin ligands having antidepressant activity as well as sleep inducing properties |
| 07/19/2007 | WO2007058998A3 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 07/19/2007 | WO2007031333A3 Improvements in or relating to amphoteric liposomes |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | WO2006016828A8 Use of alpha ketoglutarate for treating alzheimer, parkinson |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167522 Branched carboxylic acid compound and use thereof |
| 07/19/2007 | US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167487 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/19/2007 | US20070167483 Phenylalanine Enamide Derivatives |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167455 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 07/19/2007 | US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES |
| 07/19/2007 | US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167403 Remedy for spinal canal stenosis |
| 07/19/2007 | US20070167378 Iodinated diflunisal derivatives, e.g., 5-(2,4-difluorophenyl)-3-iodo-salicylic acid and N-[5-(2,4-difluorophenyl)-3-iodo-salicyloyl]glycine; treatment of neurodegenerative diseases and other conditions such as polyneuropathies and rheumatic diseases |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070167359 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 07/19/2007 | US20070166813 Gaucher disease drugs and methods of identifying same |
| 07/19/2007 | US20070166802 West nile vaccine |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070166326 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166325 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166324 West Nile vaccine |
| 07/19/2007 | US20070166290 CNS glial restricted precursor cells which generate oligodendrocytes and at least two distinct populations of astrocytes, but not neurons; isolated from a mixture of cells by positive immunoselection with an A2B5 antibody |
| 07/19/2007 | DE202007003503U1 Galatenoside und deren Verwendung als Antidepressiva Galatenoside and their use as antidepressants |
| 07/19/2007 | CA2636618A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | CA2636601A1 Novel melatonin ligands having antidepressant activity as well as sleep inducing properties |
| 07/19/2007 | CA2636333A1 Compositions and methods of treatment using modulators of motonueron diseases |
| 07/19/2007 | CA2636042A1 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 07/19/2007 | CA2635949A1 Controlled release formulation of divalproic acid and its derivatives |
| 07/19/2007 | CA2633918A1 Substituted imidazoline derivatives |
| 07/19/2007 | CA2633734A1 Substituted thiazoles and their use for producing drugs |
| 07/19/2007 | CA2633722A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/19/2007 | CA2633633A1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 07/19/2007 | CA2633581A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 07/18/2007 | EP1808484A1 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/18/2007 | EP1808446A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808432A1 Amorphous object of cinnamide compound |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1808169A2 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 07/18/2007 | EP1807440A2 Novobiocin analogues as anticancer agents |
| 07/18/2007 | EP1807434A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |